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ABSTRACT 
 
In mammals, fear conditioning is influenced by both the adrenergic system as it contributes to consolidation 
and reconsolidation of memories and the cerebellum as it relates to the consolidation of fear based 
memories. The arcopallium, posterior pallial amygdala, and cerebellum are thought to be homologs to the 
mammalian amygdala and cerebellum respectively. The adrenergic system appears to have a conserved 
distribution, but species specializations for cued memory have been found. We have previously shown that 
several functions of the cerebellum are conserved between mammalian species and the zebra finch. Lesions 
of the cerebellum result in deficits in spatial learning, postural adjustments, and timing of learned 
vocalizations. In contrast, we have tested for a conserved role of the adrenergic system in spatial and cued 
fear conditioning memory and have found no evidence that different doses of adrenergic antagonists, either 
given at several time points or chronically during learning, affect learning or retention of memory in spatial & 
cued fear conditioning tasks as they do in rodents. The neural circuitry underlying fear conditioning is well 
known and, because the β-adrenergic receptor system and cerebellum are known to be involved in fear 
conditioning, we tested whether the β-adrenergic antagonist, propranolol, would interfere with retention of 
fear memories. We did not see any behavioral deficits in learning or retention under these conditions. Thus, 
it appears that the role of the adrenergic system in fear conditioning is not conserved across species.  
 
 
INTRODUCTION & BACKGROUND 
 
Short-term memories (STM) must be 
converted to long-term memories (LTM) 
through consolidation1, 2. Reactivation of 
these memories to an active state allows 
them to be modified before becoming 
reconsolidated3,4. The adrenergic (AR) 
system is involved in the consolidation and 
reconsolidation of limbic system-
dependent memories5. In mammals, AR 
receptor antagonists, such as the non-
selective β-AR antagonist, propranolol, 
impair spatial and emotional memory if 
administered after reactivation4,6,7,8,9. In 
chick models, the AR system is involved in 
classical conditioning of taste aversion and 
contextual learning6.  In previous 
experiments, our lab has investigated the 
effects of propranolol and an α-AR 
antagonist, phentalomine, on zebra finch 
learning and consolidation during a spatial 
maze protocol. Memory was not impaired 
when given 20-mg/kg dose of 
phentolamine or 20 mg/kg and 40 mg/kg 
doses and administered 0 or 25 minutes 
before or after reactivation or administered 
chronically for propranolol. In the present 
study, we examined the zebra finch model 
to confirm a conserved role of AR system in 
reconsolidation of memory after a fear-
conditioning protocol.  
 
MATERIAL & METHODS 
 
Fear Chamber: We used an adapted fear 
conditioning chamber with a grid floor.  A 
routed PVC sheet was fitted under the floor 
to ensure the bird’s feet connected with a 
minimum of 2 different bars at a time. 
Electrode gel was applied to the feet to 
increase conductivity. Speakers emitted a 
pure tone stimulus of 800 Hz. 
Pairing: low-frequency tone (conditioned 
stimulus; CS) with 3.5mA foot shock (US). 
Males (n=18) received 5 trials/day for 7 
 days, inter-trial intervals varied among 4 
durations (60, 80, 100 or 120s) to provide 
a control against prediction. Flight 
Response duration and latency to 
response following CS onset were 
recorded using an image analyzer 
(Ethovision). 24 hr post-training, birds 
were assigned to 4 treatments: 
propranolol or saline 5m before 
reactivation, propranolol or saline 5m after 
reactivation. A single extinction trial (CS 
only) was used as a reactivation trial that 
should impair memory. A recall trail (CS-
US paired) was given 48hr post-injection 
and..reactivation. 
 
RESULTS 
 
No differences existed between groups prior to treatment on either the training trials or 
the reactivation trail (not shown) and there were no differences in recall between 
subjects in the post-injection recall trail (Figure 1). 
 
 
  
FIGURE	1.	Post-Injection	Recall	Trial.	No	significant	differences	between	the	groups	in	Flight	Response	
duration	or	latency	to	response.	The	birds	that	learned	the	fear-conditioning	protocol	should	show	longer	
flight	duration	and	shorter	latency	to	flight.	There	were	no	differences	in	learning	shown	between	the	groups.		
 
 
IV. CONCLUSION 
 
AR antagonists do not alter fear 
memory reconsolidation in zebra 
finches. The role of the AR system in 
reconsolidation of this memory type 
may not be conserved. The effective 
injection times and doses vary among 
tasks, species9, and systemic versus 
local administration complicating 
experimental identification of effects. 
To avoid repeated testing of animals at 
a large number of post learning 
injection times, we will next examine 
the location of immediate early gene 
activation that occurs during fear 
conditioning with and without an 
adrenergic antagonist. While we have 
yet to see behavioral differences 
caused by adrenergic antagonists due 
to timing precision for the 
administration of the treatments, we 
are hoping to see possible IEG 
expression differences in the brain of 
the zebra finch. The length of clearing 
time for antagonists will allow us to see 
decreases in IEG activation that 
antagonists caused over the 30 
minutes between consolidation 
learning and sacrifice These 
experiments should clearly show the 
parts of the brain involved in fear 
conditioning.  
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